{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:00:58Z","timestamp":1784991658856,"version":"3.55.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Understanding how prior policies, systemic factors, and public health events have shaped mammography use among US women is essential for interpreting the 2024 US Preventive Services Task Force (USPSTF) recommendation update and identifying gaps to inform equitable public health strategies.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To analyze mammography use trends in US women aged 40 to 49 and 50 to 74 years from 2002 to 2022 and assess variation by sociodemographic, health care access, behavioral, and geographic factors, including associations with the 2009 USPSTF recommendation and the COVID-19 pandemic.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional study used data from the Behavioral Risk Factor Surveillance System biennial cancer screening module (2002-2022). Joinpoint regression with a jump model was used to account for methodological changes in the Behavioral Risk Factor Surveillance System beginning in 2011. Data were analyzed from March to September 2025.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the average biennial percentage change in mammography use from 2002 to 2022, calculated as a weighted average of jump model\u2013estimated biennial changes. Subgroup analyses were conducted by sociodemographic, health care access, behavioral, and geographic factors.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 2\u202f619\u202f292 US women, mammography use showed a downward trend, with nonsignificant biennial changes of \u22120.54% (95% CI, \u22121.25% to 0.16%) for ages 40 to 49 years and \u22120.16% (95% CI, \u22120.49% to 0.16%) for ages 50 to 74 years from 2002 to 2022. Declines were significant among young women without health insurance (\u20131.54%; 95% CI, \u20132.89% to \u20130.17%), current smokers (\u20131.36%; 95% CI, \u20132.43% to \u20130.27%), unmarried women (\u20131.10%; 95% CI, \u20131.61% to \u20130.59%), and non-Hispanic White women (\u20130.58%; 95% CI, \u20131.09% to \u20130.07%). Following the 2009 USPSTF recommendation, mammography use decreased significantly among younger non-Hispanic White (\u22120.88%; 95% CI, \u22121.59% to \u22120.16%), Asian (\u22122.45%; 95% CI, \u22124.20% to \u22120.25%), and uninsured (\u22122.39%; 95% CI, \u22124.57% to \u22120.16%) women, with no significant reduction among non-Hispanic Black women (\u22120.59%; 95% CI, \u22121.20% to 0.03%). Across both age groups, mammography use was consistently lower in Western than in Eastern states.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study, mammography use did not significantly decline in the overall population; however, significant reductions were observed among non-Hispanic White, Asian, and uninsured women aged 40 to 49 years from 2010 to 2022. These findings highlight the need for clear, risk-based screening communication and targeted strategies to promote guideline-concordant decision-making, particularly among younger women.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.3529","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:30:33Z","timestamp":1774539033000},"page":"e263529","source":"Crossref","is-referenced-by-count":2,"title":["Trends in Mammography Use Among Women Aged 40 to 74 Years in the US, 2002-2022"],"prefix":"10.1001","volume":"9","author":[{"given":"Syed Mahfuz","family":"Al Hasan","sequence":"first","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetunji T.","family":"Toriola","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri"},{"name":"Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"1","key":"zoi260142r1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025.","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"zoi260142r2","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1001\/jama.2015.13183","article-title":"Benefits and harms of breast cancer screening: a systematic review.","volume":"314","author":"Myers","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"zoi260142r3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2471\/BLT.24.292529","article-title":"Screening programmes and breast cancer mortality: an observational study of 194 countries.","volume":"103","author":"Al Hasan","year":"2025","journal-title":"Bull World Health Organ"},{"issue":"24","key":"zoi260142r4","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","article-title":"Breast-cancer screening\u2014viewpoint of the IARC Working Group.","volume":"372","author":"Lauby-Secretan","year":"2015","journal-title":"N Engl J Med"},{"issue":"9855","key":"zoi260142r5","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review.","volume":"380","author":"Marmot","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"zoi260142r6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.7326\/0003-4819-151-10-200911170-00008","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"151","author":"Calonge","year":"2009","journal-title":"Ann Intern Med"},{"issue":"22","key":"zoi260142r7","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","article-title":"Screening for breast cancer: US Preventive Services Task Force Recommendation Statement.","volume":"331","author":"Nicholson","year":"2024","journal-title":"JAMA"},{"issue":"15","key":"zoi260142r8","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society.","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"key":"zoi260142r9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.clinimag.2021.11.025","article-title":"Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: a review.","volume":"82","author":"Tsapatsaris","year":"2022","journal-title":"Clin Imaging"},{"issue":"9","key":"zoi260142r10","doi-asserted-by":"publisher","first-page":"10877","DOI":"10.1002\/cam4.5793","article-title":"The role of facility and patient mix factors on recovery of screening and diagnostic mammography volumes following the initial COVID-19 pandemic wave.","volume":"12","author":"Lomahan","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"zoi260142r11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-021-06252-1","article-title":"Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors.","volume":"189","author":"Miller","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"zoi260142r12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1177\/00031348221087920","article-title":"Impact of the COVID-19 pandemic on breast cancer screening and operative treatment.","volume":"88","author":"Cairns","year":"2022","journal-title":"Am Surg"},{"issue":"2","key":"zoi260142r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.58141","article-title":"Socioeconomic and geographic differences in mammography trends following the 2009 USPSTF policy update.","volume":"8","author":"Semprini","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"22","key":"zoi260142r14","first-page":"410","article-title":"Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates.","volume":"61","author":"Pierannunzi","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi260142r16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev.publhealth.031308.100226","article-title":"The behavioral risk factors surveillance system: past, present, and future.","volume":"30","author":"Mokdad","year":"2009","journal-title":"Annu Rev Public Health"},{"issue":"RR-9","key":"zoi260142r17","first-page":"1","article-title":"Public health surveillance for behavioral risk factors in a changing environment recommendations from the Behavioral Risk Factor Surveillance Team.","volume":"52","author":"Mokdad","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"zoi260142r18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"3","key":"zoi260142r21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"9","key":"zoi260142r22","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1080\/02664763.2022.2063265","article-title":"Data-driven choice of a model selection method in joinpoint regression.","volume":"50","author":"Kim","year":"2022","journal-title":"J Appl Stat"},{"issue":"1","key":"zoi260142r23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2478\/jos-2020-0003","article-title":"The joinpoint-jump and joinpoint-comparability ratio model for trend analysis with applications to coding changes in health statistics.","volume":"36","author":"Chen","year":"2020","journal-title":"J Off Stat"},{"issue":"1","key":"zoi260142r24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.18865\/ed.31.1.119","article-title":"Trust and mistrust in shaping adaptation and de-implementation in the context of changing screening guidelines.","volume":"31","author":"Shelton","year":"2021","journal-title":"Ethn Dis"},{"issue":"5","key":"zoi260142r25","first-page":"531","article-title":"Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.","volume":"36","author":"Tangka","year":"2025","journal-title":"Cancer Causes Control"},{"issue":"6","key":"zoi260142r26","first-page":"477","article-title":"Breast cancer statistics 2024.","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"zoi260142r27","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1158\/1055-9965.EPI-25-0628","article-title":"Prevalence and determinants of mammography use among women aged 40 to 49 Years in the US.","volume":"34","author":"Al Hasan","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"zoi260142r29","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.230161","article-title":"Long-term mammography screening trends and predictors of return to screening after the COVID-19 pandemic: results from a statewide registry.","volume":"6","author":"Sprague","year":"2024","journal-title":"Radiol Imaging Cancer"},{"issue":"15","key":"zoi260142r31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.15585\/mmwr.mm7315e1","article-title":"Vital signs: mammography use and association with social determinants of health and health-related social needs among women\u2014United States, 2022.","volume":"73","author":"Miller","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"zoi260142r32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsb1706645","article-title":"Health insurance coverage and health: what the recent evidence tells us.","volume":"377","author":"Sommers","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi260142r35","doi-asserted-by":"crossref","first-page":"30.e1","DOI":"10.1016\/j.ajog.2011.04.005","article-title":"Attitudes of women in their forties toward the 2009 USPSTF mammogram guidelines: a randomized trial on the effects of media exposure.","volume":"205","author":"Davidson","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"zoi260142r33","volume-title":"America\u2019s Uninsured Crisis: Consequences for Health and Health Care","author":"Institute of Medicine Committee on Health Insurance Status and Its Consequences","year":"2009"},{"key":"zoi260142r15","unstructured":"Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS) annual survey data. August 28, 2024. Accessed July 13, 2025. https:\/\/www.cdc.gov\/brfss\/annual_data\/annual_data.htm"},{"key":"zoi260142r19","unstructured":"Centers for Disease Control and Prevention. BRFSS statistical brief on breast cancer screening. September 2019. Accessed February 19, 2026. https:\/\/www.cdc.gov\/brfss\/data_documentation\/pdf\/brfss-statistical-brief-breast-cancer-screening-questions-508.pdf"},{"key":"zoi260142r20","unstructured":"Centers for Disease Control and Prevention. The BRFSS data user guide. August 15, 2013. Accessed July 13, 2025. https:\/\/www.cdc.gov\/brfss\/data_documentation\/pdf\/UserguideJune2013.pdf"},{"key":"zoi260142r28","unstructured":"American Cancer Society. Cancer prevention & early detection facts & figures 2025-2026. May 2025. Accessed February 16, 2026. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/cancer-prevention-and-early-detection-facts-and-figures\/2025-cped-files\/cped-cff-2025-2026.pdf"},{"key":"zoi260142r30","unstructured":"National Cancer Institute. Cancer trends progress report: breast cancer screening. 2025. Accessed September 14, 2025. https:\/\/progressreport.cancer.gov\/detection\/breast_cancer?utm_source=chatgpt.com"},{"key":"zoi260142r34","unstructured":"Radley? D, Baumgartner? J, Collins? S, Zephyrin? L. The Commonwealth Fund 2023 scorecard on state health system performance: Americans\u2019 health declines and access to reproductive care shrinks, but states have options. June 22, 2023. Accessed September 14, 2025. https:\/\/www.commonwealthfund.org\/publications\/scorecard\/2023\/jun\/2023-scorecard-state-health-system-performance"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846958\/al_hasan_2026_oi_260142_1773945486.67451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:30:39Z","timestamp":1774539039000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.3529","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}